serw-MX  [xml]  
 


    
 DeCS Categories

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.472 Hormones .
D27.505.696.399.472.858 Progestins .
E05 Investigative Techniques .
E05.337 Evaluation Studies as Topic .
E05.337.820 Program Evaluation .
N03 Health Care Economics and Organizations .
N03.219 Economics .
N03.219.151 Costs and Cost Analysis .
N03.219.151.125 Cost-Benefit Analysis .
N04 Health Services Administration .
N04.761 Quality of Health Care .
N04.761.685 Program Evaluation .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.335 Evaluation Studies as Topic .
N05.715.360.650 Program Evaluation .
SP1 Health Policy, Planning and Management .
SP1.011 Health Administration .
SP1.011.122 Health Evaluation .
SP1.011.122.158 Program Evaluation .
SP4 Environmental Health .
SP4.006 Environmental Engineering .
SP4.006.067 Environmental Economics .
SP4.006.067.548 Cost-Benefit Analysis .
SP4.051 General Aspects .
SP4.051.497 Costs and Cost Analysis .
SP4.051.497.018 Cost-Benefit Analysis .
SP4.051.542 Evaluation Studies as Topic .
SP5 Epidemiology and Biostatistics .
SP5.001 Epidemiology .
SP5.001.047 Uses of Epidemiology .
SP5.001.047.138 Evaluation of the Efficacy-Effectiveness of Interventions .
SP5.001.047.158 Effectiveness .
SP8 Disasters .
SP8.473 Risk 17142 .
SP8.473.981 Disaster Vulnerability .
SP8.473.981.937 Socioeconomic Factors .
SP8.473.981.937.872 Cost-Benefit Analysis .
SP8.946 Disaster Management .
SP8.946.351 Impact of Disasters .
SP8.946.351.424 Damage Assessment Methodologies .
SP8.946.351.424.432 Cost-Benefit Analysis .
SP8.946.819 Prevention and Mitigation .
SP8.946.819.784 Cost-Benefit Analysis .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Program Evaluation .
Family Planning Program Evaluation .
Program Appropriateness .
Program Effectiveness .
Program Sustainability .
Appropriateness, Program .
Effectiveness, Program .
Evaluations, Program .
Program Evaluations .
Program Sustainabilities .
Sustainabilities, Program .
Sustainability, Program .
Evaluation, Program .
Evaluation, Project .
Health Program and Project Evaluation .
Project Evaluation .
Projects Evaluation .
Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact. .
1.00
242054695
 
Effectiveness .
Is a measure of the extent to which a specific intervention, procedure, regimen, or service, when deployed in the field in routine circumstaces, fulfills its objectives. .
0.80
2620
 
Evaluation Studies as Topic .
Critique .
Evaluation Indexes .
Evaluation Methodology .
Evaluation Report .
Evaluation Research .
Methodology, Evaluation .
Pre-Post Tests .
Qualitative Evaluation .
Quantitative Evaluation .
Theoretical Effectiveness .
Use-Effectiveness .
Critiques .
Effectiveness, Theoretical .
Evaluation Methodologies .
Evaluation Reports .
Evaluation, Qualitative .
Evaluation, Quantitative .
Evaluations, Qualitative .
Evaluations, Quantitative .
Indexes, Evaluation .
Methodologies, Evaluation .
Pre Post Tests .
Pre-Post Test .
Qualitative Evaluations .
Quantitative Evaluations .
Report, Evaluation .
Reports, Evaluation .
Research, Evaluation .
Test, Pre-Post .
Tests, Pre-Post .
Use Effectiveness .
Evaluation Methods .
Evaluation Techniques .
Status Report .
Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. .
0.67
320120532
 
Evaluation of the Efficacy-Effectiveness of Interventions .
Efficacy-Effectiveness .
Procedure to systematically and objectively determine the efficiency (beneficial effect under ideal conditions) and effectiveness (beneficial effect under routine conditions) for preventive interventions. .
0.66
1310
 
Progestins .
Gestagen .
Gestagen Effect .
Gestagen Effects .
Gestagenic Agents .
Gestagenic Effect .
Gestagenic Effects .
Gestagens .
Progestagenic Agents .
Progestagens .
Progestational Agents .
Progestational Compounds .
Progestational Hormones .
Progestin .
Progestin Effect .
Progestin Effects .
Progestogen Effect .
Progestogen Effects .
Effect, Gestagen .
Effect, Gestagenic .
Effect, Progestin .
Effect, Progestogen .
Effects, Gestagen .
Effects, Gestagenic .
Effects, Progestin .
Effects, Progestogen .
Progestogens .
Progestational Hormones .
Progestational Hormone Analogs .
Progestin Analogs .
Progestational Hormones, Synthetic .
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. .
0.65
1328670
 
Cost-Benefit Analysis .
Benefits and Costs .
Cost Benefit .
Cost Benefit Analysis .
Cost-Effectiveness Analysis .
Cost-Utility Analysis .
Costs and Benefits .
Economic Evaluation .
Marginal Analysis .
Analyses, Cost Benefit .
Analyses, Cost-Benefit .
Analyses, Cost-Utility .
Analyses, Marginal .
Analysis, Cost Benefit .
Analysis, Cost-Benefit .
Analysis, Cost-Effectiveness .
Analysis, Cost-Utility .
Analysis, Marginal .
Cost Benefit Analyses .
Cost Benefit Data .
Cost Effectiveness Analysis .
Cost Utility Analysis .
Cost-Benefit Analyses .
Cost-Utility Analyses .
Data, Cost-Benefit .
Economic Evaluations .
Effectiveness, Cost .
Evaluation, Economic .
Evaluations, Economic .
Marginal Analyses .
Cost Effectiveness .
Cost-Benefit Data .
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results. .
0.64
123370589